US Patent 8895581 1

Patent 8895581 was granted and assigned to Boehringer Ingelheim on November, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Boehringer Ingelheim

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8895581

Date of Patent

November 25, 2014

Patent Application Number

13697034

Date Filed

May 17, 2011

Patent Citations Received

‌

US Patent 12077539 Imidazole and triazole KRAS inhibitors

‌

US Patent 11767320 Bicyclic dione compounds as inhibitors of KRAS

‌

US Patent 11939328 Quinoline compounds as inhibitors of KRAS

‌

US Patent 11999752 Vinyl imidazole compounds as inhibitors of KRAS

Patent Primary Examiner

‌

Golam M. M. Shameem

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8895581 1

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API